<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08437026887032</udiDi>
    <basicUdiDi>8437026887AD001YH</basicUdiDi>
    <tradeName>MAP-AD Test Oligos - Oligo2-Fw</tradeName>
    <deviceName>MAP-AD Test Oligos</deviceName>
    <manufacturerName>ADmit Therapeutics</manufacturerName>
    <manufacturerSrn>ES-MF-000042518</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010201</emdnCode>
    <emdnDescription>ALZHEIMER'S DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AD001-03</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:37:01.667Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437026887025</udiDi>
    <basicUdiDi>8437026887AD001YH</basicUdiDi>
    <tradeName>MAP-AD Test Oligos - Oligo1-Rev</tradeName>
    <deviceName>MAP-AD Test Oligos</deviceName>
    <manufacturerName>ADmit Therapeutics</manufacturerName>
    <manufacturerSrn>ES-MF-000042518</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010201</emdnCode>
    <emdnDescription>ALZHEIMER'S DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AD001-02</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:55.668Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437026887018</udiDi>
    <basicUdiDi>8437026887AD001YH</basicUdiDi>
    <tradeName>MAP-AD Test Oligos - Oligo1-Fw</tradeName>
    <deviceName>MAP-AD Test Oligos</deviceName>
    <manufacturerName>ADmit Therapeutics</manufacturerName>
    <manufacturerSrn>ES-MF-000042518</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010201</emdnCode>
    <emdnDescription>ALZHEIMER'S DISEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AD001-01</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:54.466Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942840</udiDi>
    <basicUdiDi>8437016942GVS-MTH-MRE</basicUdiDi>
    <tradeName>Genvinset® MTHFR multiplex 96 test</tradeName>
    <deviceName>Genvinset® MTHFR multiplex</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010116</emdnCode>
    <emdnDescription>OTHER THROMBOPHILIA MUTATIONS (PROC, PROS1, MTHFR, SERPINC1, SEPINE1, F11, F12, F13, OTHER F2/F5)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-MTH-M-96</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:33.100Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942833</udiDi>
    <basicUdiDi>8437016942GVS-MTH-MRE</basicUdiDi>
    <tradeName>Genvinset® MTHFR multiplex 48 test</tradeName>
    <deviceName>Genvinset® MTHFR multiplex</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010116</emdnCode>
    <emdnDescription>OTHER THROMBOPHILIA MUTATIONS (PROC, PROS1, MTHFR, SERPINC1, SEPINE1, F11, F12, F13, OTHER F2/F5)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-MTH-M-48</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:26.840Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942826</udiDi>
    <basicUdiDi>8437016942GVS-MTH-MRE</basicUdiDi>
    <tradeName>Genvinset® MTHFR multiplex 24 test</tradeName>
    <deviceName>Genvinset® MTHFR multiplex</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010116</emdnCode>
    <emdnDescription>OTHER THROMBOPHILIA MUTATIONS (PROC, PROS1, MTHFR, SERPINC1, SEPINE1, F11, F12, F13, OTHER F2/F5)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-MTH-M-24</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:25.643Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942819</udiDi>
    <basicUdiDi>8437016942GVS-HFEM3T</basicUdiDi>
    <tradeName>Genvinset® HFE multiplex 96 test</tradeName>
    <deviceName>Genvinset® HFE multiplex</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010105</emdnCode>
    <emdnDescription>HAEMOCHROMATOSIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-HFE-M-96</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:24.450Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942802</udiDi>
    <basicUdiDi>8437016942GVS-HFEM3T</basicUdiDi>
    <tradeName>Genvinset® HFE multiplex 48 test</tradeName>
    <deviceName>Genvinset® HFE multiplex</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010105</emdnCode>
    <emdnDescription>HAEMOCHROMATOSIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-HFE-M-48</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:23.245Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942796</udiDi>
    <basicUdiDi>8437016942GVS-HFEM3T</basicUdiDi>
    <tradeName>Genvinset® HFE multiplex 24 test</tradeName>
    <deviceName>Genvinset® HFE multiplex</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010105</emdnCode>
    <emdnDescription>HAEMOCHROMATOSIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-HFE-M-24</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:17.242Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942758</udiDi>
    <basicUdiDi>8437016942GVS-S65CZR</basicUdiDi>
    <tradeName>Genvinset® HFE S65C 96 test</tradeName>
    <deviceName>Genvinset® HFE S65C</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010105</emdnCode>
    <emdnDescription>HAEMOCHROMATOSIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-S65C-96</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:07.636Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942697</udiDi>
    <basicUdiDi>8437016942GVS-FIIQP</basicUdiDi>
    <tradeName>Genvinset® Factor II G20210A 96 test</tradeName>
    <deviceName>Genvinset® Factor II G20210A</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010114</emdnCode>
    <emdnDescription>PROTHROMBIN MUTATION</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-FII-96</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:06.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942666</udiDi>
    <basicUdiDi>8437016942GVS-B5CF</basicUdiDi>
    <tradeName>Genvinset® HLA Behçet v5 48 tests</tradeName>
    <deviceName>Genvinset® HLA Behçet v5</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-B505-48</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:05.232Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942659</udiDi>
    <basicUdiDi>8437016942GVS-B5CF</basicUdiDi>
    <tradeName>Genvinset® HLA Behçet v5 24 tests</tradeName>
    <deviceName>Genvinset® HLA Behçet v5</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-B505-24</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:36:04.032Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942642</udiDi>
    <basicUdiDi>8437016942GVS-B27LX</basicUdiDi>
    <tradeName>Genvinset® HLA B27v5 48 tests</tradeName>
    <deviceName>Genvinset® HLA B27v5</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-B2705-48</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:35:58.044Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942635</udiDi>
    <basicUdiDi>8437016942GVS-B27LX</basicUdiDi>
    <tradeName>Genvinset® HLA B27v5 24 tests</tradeName>
    <deviceName>Genvinset® HLA B27v5</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-B2705-24</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:35:56.931Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942536</udiDi>
    <basicUdiDi>8437016942GVS-LACQH</basicUdiDi>
    <tradeName>Genvinset® Lactose Intolerance 48 tests</tradeName>
    <deviceName>Genvinset® Lactose Intolerance</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010499</emdnCode>
    <emdnDescription>POLYMORPHISM TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-LAC-48</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:35:54.428Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942529</udiDi>
    <basicUdiDi>8437016942GVS-LACQH</basicUdiDi>
    <tradeName>Genvinset® Lactose Intolerance 24 tests</tradeName>
    <deviceName>Genvinset® Lactose Intolerance</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010499</emdnCode>
    <emdnDescription>POLYMORPHISM TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-LAC-24</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:35:53.228Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942512</udiDi>
    <basicUdiDi>8437016942GVS-DQPRK</basicUdiDi>
    <tradeName>Genvinset® HLA Celiac Plus 48 tests</tradeName>
    <deviceName>Genvinset® HLA Celiac Plus</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-DQP-48</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:35:47.219Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942505</udiDi>
    <basicUdiDi>8437016942GVS-DQPRK</basicUdiDi>
    <tradeName>Genvinset® HLA Celiac Plus 24 tests</tradeName>
    <deviceName>Genvinset® HLA Celiac Plus</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GVS-DQP-24</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:35:46.039Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437016942475</udiDi>
    <basicUdiDi>8437016942AD-FMR178</basicUdiDi>
    <tradeName>Adellgene® Fragile X 100 tests</tradeName>
    <deviceName>Adellgene® Fragile X</deviceName>
    <manufacturerName>Blackhills Diagnostic Resources S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000001091</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010104</emdnCode>
    <emdnDescription>FRAGILE X SYNDROME</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AD-FMR1-100</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:35:37.618Z</lastUpdated>
  </row>
</eudamedExport>